BMTjournal Profile Banner
Bone Marrow Transplantation Profile
Bone Marrow Transplantation

@BMTjournal

Followers
4K
Following
5
Statuses
417

Publishing high quality, peer reviewed original research & reviews addressing all aspects of basic biology and clinical use of haemopietic cell transplantation

London, England
Joined September 2018
Don't wanna be here? Send us removal request.
@BMTjournal
Bone Marrow Transplantation
3 years
Hematopoietic stem cell transplantation and cellular therapies for autoimmune diseases: overview and future considerations from the Autoimmune Diseases Working Party (ADWP) of the EBMT ⁦@BMTjournal
0
10
32
@BMTjournal
Bone Marrow Transplantation
3 years
Treosulfan plus fludarabine versus TEAM as conditioning treatment before autologous stem cell transplantation for B-cell Non-Hodgkin lymphoma | Bone Marrow Transplantation
0
4
21
@BMTjournal
Bone Marrow Transplantation
3 years
Male-specific late effects in adult hematopoietic cell transplantation recipients: a systematic review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT
0
5
15
@BMTjournal
Bone Marrow Transplantation
3 years
Rates and predictors of infusion-related reactions in patients receiving standard versus prolonged infusion of rabbit anti-thymocyte globulin for hematopoietic stem cell transplantation, a retrospective analysis | Bone Marrow Transplantation
0
3
9
@BMTjournal
Bone Marrow Transplantation
3 years
Addition and drug monitoring of mycophenolate mofetil for GVHD prophylaxis in unrelated bone marrow transplantation | Bone Marrow Transplantation
0
2
8
@BMTjournal
Bone Marrow Transplantation
3 years
CD34+ -selected hematopoietic stem cell transplant conditioned with a myeloablative regimen in patients with advanced myelofibrosis | Bone Marrow Transplantation
0
2
8
@BMTjournal
Bone Marrow Transplantation
3 years
Low-dose unfractionated heparin prophylaxis is a safe strategy for the prevention of hepatic sinusoidal obstruction syndrome after myeloablative adult allogenic stem cell transplant | Bone Marrow Transplantation
0
3
13
@BMTjournal
Bone Marrow Transplantation
3 years
Neutralizing antibody and T cell responses to SARS-CoV-2 vaccination in hematopoietic cell transplant recipients | Bone Marrow Transplantation
0
1
4
@BMTjournal
Bone Marrow Transplantation
3 years
Comparative analysis of Decitabine intensified BUCY2 and BUCY2 conditioning regimen for high-risk MDS patients undergoing allogeneic hematopoietic stem cell transplantation | Bone Marrow Transplantation
0
3
13
@BMTjournal
Bone Marrow Transplantation
3 years
Endothelial complications after allogeneic stem cell transplantation in patients with pretransplant resolved COVID-19 | Bone Marrow Transplantation
0
2
10
@BMTjournal
Bone Marrow Transplantation
3 years
Safety and feasibility of outpatient chimeric antigen receptor (CAR) T-cell therapy: experience from a tertiary care center | Bone Marrow Transplantation
0
6
18
@BMTjournal
Bone Marrow Transplantation
3 years
Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01 | Bone Marrow Transplantation #bmtsm
0
8
25
@BMTjournal
Bone Marrow Transplantation
3 years
Autologous stem cell transplantation for multiple myeloma patients with chronic kidney disease: a safe and effective option | Bone Marrow Transplantation @bmtsm
0
3
9
@BMTjournal
Bone Marrow Transplantation
3 years
Impact of maintenance therapy post autologous stem cell transplantation for multiple myeloma in early and delayed transplant | Bone Marrow Transplantation
0
2
6
@BMTjournal
Bone Marrow Transplantation
3 years
The impact of HLA donor-specific antibodies on engraftment and the evolving desensitization strategies | Bone Marrow Transplantation
0
8
19
@BMTjournal
Bone Marrow Transplantation
3 years
Haemophagocytic lymphohistiocytosis following allogeneic hematopoietic cell transplantation from mismatched unrelated donors associated with low CD34 and CD3 cell counts in the graft | Bone Marrow Transplantation
0
2
8
@BMTjournal
Bone Marrow Transplantation
3 years
Profile of capillary-leak syndrome in patients received chimeric antigen receptor T cell therapy | Bone Marrow Transplantation
0
1
1
@BMTjournal
Bone Marrow Transplantation
3 years
Effect of early granulocyte-colony-stimulating factor administration in the prevention of febrile neutropenia and impact on toxicity and efficacy of anti-CD19 CAR-T in patients with relapsed/refractory B-cell lymphoma | Bone Marrow Transplantation
0
1
7
@BMTjournal
Bone Marrow Transplantation
3 years
Profile of capillary-leak syndrome in patients received chimeric antigen receptor T cell therapy | Bone Marrow Transplantation ⁦@BMTjournal
0
1
4
@BMTjournal
Bone Marrow Transplantation
3 years
Tacrolimus initial steady state level in post-transplant cyclophosphamide-based GvHD prophylaxis regimens ⁦@BMTjournal
0
2
5